Lemaitre Vascular
LMAT
Lemaitre Vascular (LMAT) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Wells Fargo | Maintained | Equal-Weight | $94.00 from $104.00 | Aug 5, 2026 |
| Barrington Research | Maintained | Outperform | $120.00 | Jun 3, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $104.00 from $94.00 | May 6, 2026 |
| Barrington Research | Maintained | Outperform | $120.00 from $105.00 | May 6, 2026 |
| Citizens | Maintained | Market Outperform | $127.00 from $118.00 | May 6, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $94.00 from $87.00 | Feb 26, 2026 |
| Roth Capital | Maintained | Buy | $117.00 from $108.00 | Feb 26, 2026 |
| Barrington Research | Maintained | Outperform | $105.00 from $95.00 | Feb 26, 2026 |
| Citizens | Maintained | Market Outperform | $118.00 from $113.00 | Feb 26, 2026 |
| Barrington Research | Maintained | Outperform | $95.00 | Feb 20, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $93.00 from $97.00 | Nov 7, 2025 |
| Roth Capital | Maintained | Buy | $108.00 | Nov 5, 2025 |
| Barrington Research | Maintained | Outperform | $95.00 | Oct 15, 2025 |
| Barrington Research | Maintained | Outperform | $95.00 | Sep 23, 2025 |
| Barrington Research | Upgraded | Market Perform → Outperform | $95.00 | Aug 6, 2025 |
| Cantor Fitzgerald | Maintained | Neutral | $95.00 from $92.00 | Aug 6, 2025 |
| Barrington Research | Maintained | Market Perform | — | Jul 22, 2025 |
| Barrington Research | Downgraded | Outperform → Market Perform | — | Feb 28, 2025 |
| Citizens Capital Markets | Maintained | Buy | $110.00 from $105.00 | Feb 28, 2025 |
| Wells Fargo | Initiated Coverage | Equal-Weight | $95.00 | Feb 13, 2025 |
Frequently asked questions
What is the latest analyst rating on LMAT?
On Aug 5, 2026, Wells Fargo maintained Lemaitre Vascular at Equal-Weight with a price target of $94.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.